You are here
PRESAGE BIOSCIENCES, INC.
UEI: QG6LWDZ313H9
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Arrayed drug microinjection for guiding precision medicine in relapsed lymphoma
Amount: $3,000,000.00DESCRIPTIONprovided by applicantImprovements in cancer diagnostics and therapeutics have positively impacted outcomes for oncology patients within select clinical nichesHoweversignificant therapeutic ...
SBIRPhase II2016Department of Health and Human Services National Institutes of Health -
Phase II of VerOFy: A New Tool to Improve Productivity for Stress Research
Amount: $288,692.00DESCRIPTION (provided by applicant): With few exceptions, extensive characterization of signal pathway alterations in cancer, and advances in our capacity to identify potent modulators of distinct mol ...
SBIRPhase I2013Department of Health and Human Services National Institutes of Health -
Sideport Needle Array Technologies for Prioritizing Drugs for Cancer Patients
Amount: $1,210,192.00DESCRIPTION (provided by applicant): Over 90% of cancer patients that enroll in Phase I or II clinical trials experience no benefit from the experimental therapies, yet are exposed to drug toxicity an ...
STTRPhase II2011Department of Health and Human Services National Institutes of Health -
Sideport Needle Array Technologies for Prioritizing Drugs for Cancer Patients
Amount: $164,492.00DESCRIPTION (provided by applicant): Over 90% of cancer patients that enroll in Phase I or II clinical trials experience no benefit from the experimental therapies, yet are exposed to drug toxicity an ...
STTRPhase I2010Department of Health and Human Services National Institutes of Health